Abstract:Abstract Background Type I interferons are widely used in research applications and as biotherapeutics. Current assays used to measure interferon concentrations, such as plaque reduction assays and ELISA, are expensive, technically challenging, and may take days to provide results. We sought to develop a robust and rapid assay to determine interferon concentrations produced from transiently transfected cell cultures. Method Indirect quantification of recombinant interferon was evaluated using a novel bi-cistronic construct encoding the Foot-and-mouth disease virus 2A translational interrupter sequence to yield equimolar expression of Gaussia princeps luciferase and porcine interferon α. Direct quantification was evaluated by expression of a novel fusion protein comprised of Gaussia princeps luciferase and porcine type I interferon. Plasmids encoding constructs are transiently transfected into cell cultures and supernatant harvested for testing of luminescence, ELISA determined concentration, and anti-viral activity against vesicular stomatitis virus. Results Bi-cistronic constructs, utilized for indirect quantification, demonstrate both luciferase activity and anti-viral activity. Fusion proteins, utilized for direct quantification, retained secretion and luminescence however only the interferon α fusion protein had antiviral activity comparable to wildtype porcine interferon α. A strong linear correlation was observed between dilution and luminescence for all compounds over a dynamic range of concentrations. Conclusion The correlation of antiviral and luciferase activities demonstrated the utility of this approach, both direct and indirect, to rapidly determine recombinant interferon concentrations. Concentration can be determined over a more dynamic concentration range than available ELISA based assays using this methodology.

Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies

Highly-sensitive reporter cell line for detection of interferon types I-III and their neutralization by antibodies

A sensitive assay for measuring whole-blood responses to type I IFNs

Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and Autoimmunity

Luciferase Reporter Systems in Investigating Interferon Antiviral Innate Immunity

Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway

Preparation,Characterization and Application of Monoclonal Antibodies to Recombinant Human Interferon—α2a

An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

Measuring HIV neutralization in a luciferase reporter gene assay

IFN-λ1 in CHO cells: its expression and biological activity

Regulation and Dynamics of IFN-β Expression Revealed with a Knockin Reporter Mouse

Early interferon lambda production is induced by double-stranded RNA in iPS-derived hepatocyte-like cells

A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity

Luciferase Reporter Assay for Determining the Signaling Activity of Interferons

Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means

An Interferon-Beta Promoter Reporter Assay for High Throughput Identification of Compounds Against Multiple RNA Viruses

IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial Infections

Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter

Engineered chimeric receptors for dissecting interferon signaling